Quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: the global DISCOVER study

被引：0
|
作者：
Nicolucci, A. [1 ]
Gomes, M. B. [2 ]
Khunti, K. [3 ]
Kosiborod, M. [4 ]
Pocock, S. [5 ]
Rathmann, W. [6 ]
Shestakova, M. V. [7 ]
Shimomura, I. [8 ]
Watada, H. [9 ]
Chen, H. [10 ]
Cid-Ruzafa, J. [11 ]
Fenici, P. [12 ]
Hammar, N. [13 ]
Tang, F. [4 ]
Ji, L. [14 ]
机构：
[1] Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy
[2] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil
[3] Univ Leicester, Leicester, Leics, England
[4] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
[5] London Sch Hyg & Trop Med, London, England
[6] German Diabet Ctr, Dusseldorf, Germany
[7] Diabet Inst, Endocrinol Res Ctr, Moscow, Russia
[8] Osaka Univ, Osaka, Japan
[9] Juntendo Univ, Tokyo, Japan
[10] AstraZeneca, Gaithersburg, MD USA
[11] Evidera, Barcelona, Spain
[12] AstraZeneca, Cambridge, England
[13] AstraZeneca Gothenburg, Molndal, Sweden
[14] Peking Univ, Peoples Hosp, Beijing, Peoples R China
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
344
引用
收藏
页码：S173 / S174
页数：2
相关论文
共 50 条
  • [1] Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER study
    Nicolucci, Antonio
    Chen, Hungta
    Cid-Ruzafa, Javier
    Cooper, Andrew
    Fenici, Peter
    Gomes, Marilia B.
    Hammar, Niklas
    Khunti, Kamlesh
    Kosiborod, Mikhail
    Leigh, Paul
    Medin, Jennie
    Rathmann, Wolfgang
    Shestakova, Marina, V
    Shimomura, Iichiro
    Siddiqui, Afrah
    Tang, Fengming
    Watada, Hirotaka
    Ji, Linong
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 180
  • [2] Second-line Glucose-Lowering Therapy in Type 2 Diabetes Mellitus
    Shin, Jung-Im
    CURRENT DIABETES REPORTS, 2019, 19 (08)
  • [3] Second-line Glucose-Lowering Therapy in Type 2 Diabetes Mellitus
    Jung-Im Shin
    Current Diabetes Reports, 2019, 19
  • [4] Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study
    Charbonnel, Bernard H.
    Chen, Hungta
    Cid-Ruzafa, Javier
    Cooper, Andrew
    Fenici, Peter
    Gomes, Marilia B.
    Saraiva, Gabriela L.
    Medina, Jesus
    Nicolucci, Antonio
    Shestakova, Marina, V
    Shimomura, Iichiro
    Surmont, Filip
    Tang, Fengming
    Vora, Jiten
    Watada, Hirotaka
    Khunti, Kamlesh
    DIABETES OBESITY & METABOLISM, 2023, 25 (01): : 46 - 55
  • [5] Treatment Patterns and Associated Clinical Outcomes in Type 2 Diabetes Patients Initiating Second-Line Glucose-Lowering Therapy: Interim Analysis of Baseline Data from Turkey Arm of the Global DISCOVER Study
    Bayram, Fahri
    Sari, Ramazan
    Kucukler, Ferit Kerim
    Araz, Mustafa
    Colak, Ramis
    Baspinar, Osman
    Kucukardali, Yasar
    Calan, Mehmet
    Yilmaz, Ceren
    Utebay, Onur
    Tetiker, Tamer
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2021, 25 (02) : 202 - 215
  • [6] Glycaemic, lipid and blood pressure control according to guidelines in patients initiating second-line glucose-lowering therapy: results from the global DISCOVER study
    Gomes, M. B.
    Charbonnel, B.
    Cid-Ruzafa, J.
    Fenici, P.
    Hammar, N.
    Khunti, K.
    Kosiborod, M.
    Nicolucci, A.
    Pocock, S.
    Shestakova, M. V.
    Watada, H.
    Shimomura, I.
    Tang, F.
    Ji, L.
    DIABETOLOGIA, 2017, 60 : S140 - S140
  • [7] Socioeconomic factors associated with hypoglycaemia in patients starting second-line glucose-lowering therapy: The DISCOVER study
    Rathmann, Wolfgang
    Charbonnel, Bernard
    Gomes, Marilia B.
    Hammar, Niklas
    Khunti, Kamlesh
    Kosiborod, Mikhail
    Kuss, Oliver
    Shestakova, Marina V.
    Watada, Hirotaka
    Shimomura, Iichiro
    Tang, Fengming
    Cid-Ruzafa, Javier
    Chen, Hungta
    Fenici, Peter
    Surmont, Filip
    Ji, Linong
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 165
  • [8] Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme
    Khunti, Kamlesh
    Gomes, Marilia B.
    Kosiborod, Mikhail
    Nicolucci, Antonio
    Pocock, Stuart
    Rathmann, Wolfgang
    Shestakova, Marina, V
    Shimomura, Iichiro
    Watada, Hirotaka
    Chen, Hungta
    Cid-Ruzafa, Javier
    Fenici, Peter
    Hammar, Niklas
    Tang, Fengming
    Ji, Linong
    BMJ OPEN, 2020, 10 (08):
  • [9] Global Prevalence of Type 2 Diabetes Complications in 14,391 Patients Initiating Second-Line Therapy: The DISCOVER Study
    Kosiborod, Mikhail
    Arya, Nikita
    Cid-Ruzafa, Javier
    Fenici, Peter
    Gomes, Marilia B.
    Hammar, Niklas
    Kamal, Samer
    Nicolucci, Antonio
    Pocock, Stuart
    Rathmann, Wolfgang
    Shestakova, Marina V.
    Shimomura, Iichiro
    Tang, Fengming
    Watada, Hirotaka
    Khunti, Kamlesh
    DIABETES, 2017, 66 : A80 - A80
  • [10] Global prevalence of type 2 diabetes complications in 14,391 patients initiating second-line therapy: the DISCOVER study
    Shestakova, M. V.
    Khunti, K.
    Arya, N.
    Cid-Ruzafa, J.
    Fenici, P.
    Gomes, M. B.
    Hammar, N.
    Nicolucci, A.
    Pocock, S.
    Rathmann, W.
    Watada, H.
    Shimomura, I.
    Tang, F.
    Kosiborod, M.
    DIABETOLOGIA, 2017, 60 : S518 - S519
12345